22.418 articles found

N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders

IGNACIO PEREZ FERNANDEZ DANIEL.

· 2007-08-01

Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders

RUBIO ARRIETA LAURA.

· 2007-08-01

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, GARCIA PALOMERO ESTHER, PEREZ FERNANDEZ DANIEL IGNACIO, DE AUSTRIA DE LUQUE CELIA, DELGADO HERNANDEZ ELENA, GARCIA FERNANDEZ PABLO, VALENZUELA LIMINANA RITA, USAN EGEA PAOLA, MARTINEZ GIL ANA, CASTRO MORERA ANA.

· 2007-08-01

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

VALENZUELA LIMINANA RITA, MEDINA PADILLA MIGUEL, GARCIA FERNANDEZ PABLO, DE AUSTRIA DE LUQUE CELIA, USAN EGEA PAOLA, RUBIO ARRIETA LAURA, GARCIA PALOMERO ESTHER, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, SANCHEZ-QUESADA JORGE, DELGADO HERNANDEZ ELENA, CASTRO MORERA ANA, MARTINEZ GIL ANA.

· 2007-08-01

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, MUNOZ RUIZ PILAR, LOPEZ OGALLA JAVIER, RUBIO ARRIETA LAURA, GARCIA PALOMERO ESTHER, GARCIA FERNANDEZ PABLO, DE AUSTRIA DE LUQUE CELIA, DELGADO HERNANDEZ ELENA, USAN EGEA PAOLA, VALENZUELA LIMINANA RITA, SANCHEZ-QUESADA JORGE.

· 2007-08-01

PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

MUNOZ RUIZ PILAR, VALENZUELA LIMINANA RITA, MARTINEZ GIL ANA, CASTRO MORERA ANA, MEDINA PADILLA MIGUEL, LOPEZ OGALLA JAVIER, RUBIO ARRIETA LAURA, GARCIA PALOMERO ESTHER, GARCIA FERNANDEZ PABLO, DE AUSTRIA DE LUQUE CELIA, DELGADO HERNANDEZ ELENA, USAN EGEA PAOLA, SANCHEZ-QUESADA JORGE.

· 2007-08-01

New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.

Kannengiesser C, Dalle S, Leccia MT, Avril MF, Bonadona V, Chompret A, Lasset C, Leroux D, Thomas L, Lesueur F, Lenoir G, Sarasin A, Bressac-de Paillerets B.

Genes Chromosomes Cancer · 2007-08-01

DOI: 10.1002/gcc.20461PMID: 17492760

Worsening of motor symptoms and gynecomastia during spironolactone treatment in a patient with Parkinson's disease and congestive heart failure.

Teive HA, Munhoz RP, Werneck LC.

Mov Disord · 2007-08-01

DOI: 10.1002/mds.21579PMID: 17534964

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.

Schoffer KL, Henderson RD, O'Maley K, O'Sullivan JD.

Mov Disord · 2007-08-01

DOI: 10.1002/mds.21428PMID: 17557339

Motor cortex stimulation for levodopa-resistant akinesia: case report.

Tani N, Saitoh Y, Kishima H, Oshino S, Hatazawa J, Hashikawa K, Yoshimine T.

Mov Disord · 2007-08-01

DOI: 10.1002/mds.21593PMID: 17557343

A progressive, fatal dystonia-Parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy.

Papapetropoulos S, Friedman J, Blackstone C, Kleiner GI, Bowen BC, Singer C.

Mov Disord · 2007-08-01

DOI: 10.1002/mds.21631PMID: 17588239

Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response.

Riepe MW, Kohler J, Horn R.

Curr Med Res Opin · 2007-08-01

DOI: 10.1185/030079907x210787PMID: 17599785